4.7 Article

Differences between painless and painful constipation among community women

Journal

AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 101, Issue 3, Pages 604-612

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1111/j.1572-0241.2006.00435.x

Keywords

-

Funding

  1. NCRR NIH HHS [M01 RR 00585] Funding Source: Medline
  2. NIAMS NIH HHS [R01 AR 30582] Funding Source: Medline
  3. NICHD NIH HHS [R01 HD 41129, R01 HD 38666] Funding Source: Medline

Ask authors/readers for more resources

BACKGROUND: In the Rome II criteria, patients with both constipation and abdominal pain (AP) (i.e., painful constipation (PC)), who do not satisfy criteria for irritable bowel syndrome (IBS) are included in the same functional constipation (FC) category as patients with constipation without AP (i.e., painless constipation (PLC)). What differences, if any, exist between FC without (i.e., PLC) and with AP (i.e., PC) are unclear. METHODS: To compare clinical features among PLC, PC, constipation-predominant IBS (C-IBS), and non-C-IBS, a validated questionnaire was mailed (with telephone follow-up of nonresponders) to an age-stratified random sample of 5,200 adult women in Olmsted County, Minnesota. RESULTS: Altogether, 2,800 women (53%) responded. The age-adjusted prevalence of PLC (7.1 per 100; 95% confidence interval (95% CI), 6.2-8.0) was higher compared to PC (0.9 per 100; 95% CI, 0.6-1.2). Compared to PLC, patients with PC reported worse general health (i.e., excellent or very good = 37.5%vs 51.2%), more somatic symptoms (mean score = 1.3 vs 0.9), and urinary urgency (% often = 58%vs 32%), and had a higher prevalence of hysterectomy. Bowel symptoms significantly impacted >= 1 domain of quality of life (QOL) in 18% of PC versus 9% of PLC. In a logistic discriminant model, age, general health, impact of bowel symptoms on QOL, somatic symptoms, and urinary urgency independently discriminated between bowel subtypes. CONCLUSIONS: Patients with PC more closely resemble those with C-IBS than PLC. Consideration should be given to separating PC from PLC in the Rome criteria and in therapeutic trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available